New research found that Tasigna may be the cure for Parkinson.
On Saturday, the doctors reported that a treatment which is usually used to treat patients from leukemia, has had some surprising effects when it was administered to some patients.
The drug is called Tasigna. Doctors hope that it will stop the progression of Parkinson based on the fact that 10 out of 12 patients improved their health condition after taking this medicine.
However, further testing is needed in order to establish if this drug can indeed be used to treat such disease, but families with ill patients already feel optimistic about it.
Tasigna, also called Nilotinib, is a drug used to treat leukemia. If it is administered in big doses, it can kill the affected cells. According to the researchers, small doses could improve the damaged brain cells that hinder the brain from functioning appropriately.
Mary Leigh is one of the patients who accepted to test the drug for Georgetown University Medical Center. Before taking the drug, she couldn’t move and her fingers swung. After she took the medicine, she felt much better, in the sense that she was able to move without help and also to eat by herself.
Researchers now try to see if this drug helps patients suffering from Alzheimer and Huntington’s disease.
Michael Okun, a neurologist from the University of Florida, was impressed by the discovery: “Nilotinib therapy focuses on the protein deposits that accumulate in the Parkinson’s disease brain. These protein deposits are called Lewy bodies,” he stated.
According to the Parkinson’s Disease Foundation, almost 1 million Americans suffer from Parkinson, characterized by stiff muscles and movement problems.
The drug is already on the market. Its cost is very high: $9,000- $10,000 for 28 pills. It may also have side effects, such as cephalalgia, sickness and tiredness.
Image Source: Staticflickr